COVID-19, influenza, and pneumococcal vaccination awareness and uptake in geriatric patients: a cross-sectional study

Abstract

Aims: Respiratory tract infections are leading causes of morbidity and mortality in the geriatric population. The COVID-19 pandemic has reinforced the critical importance of vaccination against preventable respiratory diseases in elderly individuals. This study aimed to assess awareness levels, vaccination rates, and factors influencing vaccine acceptance for COVID-19, influenza, and pneumococcal vaccines among individuals aged ≥65 years. Methods: This cross-sectional study was conducted between January 08, 2025, and February 28, 2025, involving patients aged ≥65 years who presented to the hospital for any reason. Structured interviews assessed vaccination history and awareness levels. Unvaccinated participants received standardized educational information about vaccine benefits and risks, followed by assessment of vaccination willingness. Demographic characteristics, educational level, and reasons for vaccine hesitancy were recorded. Statistical analysis was performed using SPSS v30.0, with Chi-square tests for categorical variables and p<0.05 considered significant. Results: Among 168 participants (mean age 71.9±6.3 years, 52.4% female), vaccination rates were 96.4% for COVID-19, 59.5% for influenza (past year), and 14.9% for pneumococcal vaccine (past five years). Primary reasons for non-vaccination included lack of risk group awareness for pneumococcal (62.0%) and influenza vaccines (39.4%), while perceived vaccine inefficacy dominated COVID-19 hesitancy (85.7%). However, the COVID-19 unvaccinated subgroup was very small (n=6), limiting the robustness of statistical analysis for this vaccine. Higher educational level significantly correlated with influenza (p=0.032) and pneumococcal vaccination (p=0.018). Post-education, willingness to be vaccinated increased substantially: influenza 64.1%, pneumococcal 74.2%, and COVID-19 100%. It should be noted that this study measured vaccination intention rather than actual vaccine uptake. Conclusion: Significant disparities exist in vaccination awareness and uptake across different vaccines in the geriatric population. However, as a single-center study focusing only on hospital-attending elderly adults, the generalizability of findings may be limited. Targeted educational interventions demonstrate substantial potential for improving vaccine acceptance intention. These findings highlight the need for healthcare provider-led education programs and policy initiatives to address knowledge gaps and enhance preventive care in this high-risk population.

Keywords

• Geriatrics
• COVID-19 vaccine
• influenza vaccine
• pneumococcal vaccine
• vaccination awareness
• vaccine hesitancy

COVID-19, influenza ve pnömokok aşıları hakkında farkındalık ve aşılama oranları: geriatrik hastalarda kesitsel bir çalışma

Abstract

Amaç: Solunum yolu enfeksiyonları, geriatrik popülasyonda morbidite ve mortalitenin önde gelen nedenlerindendir. COVID-19 pandemisi, yaşlı bireylerde önlenebilir solunum yolu hastalıklarına karşı aşılama uygulamalarının kritik önemini pekiştirmiştir. Bu çalışmada, 65 yaş ve üzeri bireylerde COVID-19, influenza ve pnömokok aşılarına ilişkin farkındalık düzeyleri, aşılama oranları ve aşı kabulünü etkileyen faktörlerin değerlendirilmesi amaçlanmıştır. Yöntemler: Bu kesitsel çalışma, 8 Ocak 2025 ile 28 Şubat 2025 tarihleri arasında herhangi bir nedenle hastaneye başvuran ≥65 yaş hastalarla yürütülmüştür. Yapılandırılmış görüşmelerle aşı öyküsü ve farkındalık düzeyleri değerlendirilmiştir. Aşısız katılımcılara aşıların yararları ve riskleri hakkında standartlaştırılmış eğitim bilgisi verilmiş, ardından aşılama istekliliği yeniden değerlendirilmiştir. Demografik özellikler, eğitim düzeyi ve aşı tereddütü nedenleri kaydedilmiştir. İstatistiksel analiz SPSS v30.0 programı ile yapılmış, kategorik değişkenler için ki-kare testi kullanılmış ve p<0,05 anlamlı kabul edilmiştir. Bulgular: Çalışmaya alınan 168 katılımcının (ortalama yaş 71,9±6,3 yıl; %52,4 kadın) aşılama oranları COVID-19 için %96,4, influenza için (geçen yıl) %59,5 ve pnömokok aşısı için (son beş yılda) %14,9 idi. Aşılanmama nedenleri arasında pnömokok (%62,0) ve influenza (%39,4) aşılarında risk grubu farkındalığının olmaması öne çıkarken, COVID-19 aşısına yönelik tereddütte aşıların etkisiz olduğu algısı (%85,7) baskındı. Yüksek eğitim düzeyi influenza (p=0,032) ve pnömokok aşılanması (p=0,018) ile anlamlı düzeyde ilişkili bulundu. Eğitim sonrasında aşılama istekliliği belirgin şekilde arttı: influenza %64,1, pnömokok %74,2 ve COVID-19 %100. Sonuçlar: Geriatrik popülasyonda farklı aşılar arasında farkındalık ve aşılama oranlarında önemli farklılıklar mevcuttur. Hedefe yönelik eğitim müdahaleleri, aşı kabulünü artırmada önemli potansiyele sahiptir. Bulgular, bilgi eksikliklerini gidermeye ve bu yüksek riskli grupta koruyucu sağlık hizmetlerini geliştirmeye yönelik sağlık çalışanı liderliğinde eğitim programları ve politika girişimlerinin gerekliliğini vurgulamaktadır.

Keywords

• Geriatri
• COVID-19 aşısı
• İnfluenza aşısı
• Pnömokok aşısı
• aşılama farkındalığı
• aşı tereddütü

References

1. Weinberger B. Vaccines for the elderly: current use and future challenges. Immun Ageing. 2018;15:3. doi:10.1186/s12979-017-0107-2
2. World Health Organization. Pneumococcal vaccines: WHO position paper. Wkly Epidemiol Rec. 2022;97(8):73-95.
3. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179-186. doi:10.1001/jama.289.2.179
4. Centers for Disease Control and Prevention. Vaccination recommendations for older adults. Updated 2021. Accessed April 20, 2025. https://www.cdc.gov/vaccines/adults/rec-vac/index.html
5. Verger P, Dubé E. Restoring confidence in vaccines in the COVID-19 era. Expert Rev Vaccines. 2020;19(11):991-993. doi:10.1080/14760584.2020. 1825945
6. Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225-228. doi: 10.1038/s41591-020-1124-9
7. World Health Organization. Immunization in the Context of COVID-19 Pandemic: Practical Considerations. World Health Organization; 2021.
8. Domnich A, Arata L, Amicizia D, Puig-Barberà J, Gasparini R, Panatto D. Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: a systematic review and meta-analysis. Vaccine. 2017;35(4):513-520. doi:10.1016/j.vaccine.2016.12.011

9. Kwok KO, Li KK, Wei WI, Tang A, Wong SYS, Lee SS. Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: a survey. Int J Nurs Stud. 2021;114:103854. doi:10.1016/j.ijnurstu. 2020.103854
10. Loomba S, de Figueiredo A, Piatek SJ, de Graaf K, Larson HJ. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat Hum Behav. 2021;5(3):337-348. doi:10.1038/s41562-021-01056-1
11. Forman R, Shah S, Jeurissen P, Jit M, Mossialos E. COVID-19 vaccine challenges: what have we learned so far and what remains to be done? Health Policy. 2021;125(5):553-567. doi:10.1016/j.healthpol.2021.03.013
12. Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J. Attitudes to vaccination: a critical review. Soc Sci Med. 2014;112:1-11. doi:10.1016/j.socscimed.2014.04.018
13. Porcari DE, Palmer K, Spalletta G, Ciullo V, Banaj N. A survey for examining the effects of COVID-19 and infection control measures in older persons with mild cognitive impairment and dementia and their caregivers. Front Psychiatry. 2020;11:599851. doi:10.3389/fpsyt.2020. 599851
14. Ciblak MA; Influenza Platform Working Group. Influenza vaccination in Turkiye: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate. Vaccine. 2013;31(3):518-523. doi:10.1016/j.vaccine.2012.11.022
15. Gazibara T, Kovacevic N, Kisic-Tepavcevic D, et al. Flu vaccination among older persons: study of knowledge and practices. J Health Popul Nutr. 2019;38(1):2. doi:10.1186/s41043-018-0159-8
16. Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323(24):2458-2459. doi:10.1001/jama.2020.8711
17. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18): 1775-1776. doi:10.1001/jama.2020.4683
18. World Health Organization. Global Influenza Strategy 2019-2030. World Health Organization; 2019.
19. Bonten MJM, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015; 372(12):1114-1125. doi:10.1056/NEJMoa1408544
20. Dereli F, Uyanik G, Duman JGY, Kundakçi G, Yilmaz M. Determination of immunization status of individuals aged 65 and over: family health center example. İKÇÜSBFD. 2022;7(2):291-301.
21. Kobayashi M, Pilishvili T, Farrar JL, et al. Systematic review and meta-analysis of the efficacy and effectiveness of pneumococcal vaccines in adults. Pathogens. 2023;12(5):732. doi:10.3390/pathogens12050732
22. Jennings W, Stoker G, Bunting H, et al. Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines (Basel). 2021;9(6):593. doi:10.3390/vaccines9060593
23. MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34): 4161-4164. doi:10.1016/j.vaccine.2015.04.036
24. Eilers R, Krabbe PFM, de Melker HE. Factors affecting the uptake of vaccination by the elderly in Western society. Prev Med. 2014;69:224-234. doi:10.1016/j.ypmed.2014.10.017
25. Nagata JM, Hernández-Ramos I, Kurup AS, Albrecht D, Vivas-Torrealba C, Franco-Paredes C. Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data. BMC Public Health. 2013;13:388. doi:10.1186/1471-2458-13-388
26. Okan O, Bollweg TM, Berens EM, Hurrelmann K, Bauer U, Schaeffer D. Coronavirus-related health literacy: a cross-sectional study in adults during the COVID-19 infodemic in Germany. Int J Environ Res Public Health. 2020;17(15):5503. doi:10.3390/ijerph17155503
27. Castro-Sánchez E, Chang PWS, Vila-Candel R, Escobedo AA, Holmes AH. Health literacy and infectious diseases: why does it matter? Int J Infect Dis. 2016;43:103-110. doi:10.1016/j.ijid.2015.12.019
28. Lorini C, Santomauro F, Donzellini M, et al. Health literacy and vaccination: a systematic review. Hum Vaccin Immunother. 2018;14(2): 478-488. doi:10.1080/21645515.2017.1392423
29. Kopsaftis Z, Wood-Baker R, Poole P. Influenza vaccine for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2018;6(6):CD002733. doi:10.1002/14651858.CD002733.pub3
30. Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of influenza vaccination intention and behavior-a systematic review of influenza vaccine hesitancy, 2005-2016. PLoS One. 2017;12(1):e0170550. doi:10.1371/journal.pone.0170550
31. Jarrett C, Wilson R, O’Leary M, Eckersberger E, Larson HJ; SAGE Working Group on Vaccine Hesitancy. Strategies for addressing vaccine hesitancy-a systematic review. Vaccine. 2015;33(34):4180-4190. doi:10. 1016/j.vaccine.2015.04.040